1. Home
  2. INMB vs WNEB Comparison

INMB vs WNEB Comparison

Compare INMB & WNEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INMB
    SELLHOLDBUYas of 2 days ago
  • WNEB
    SELLHOLDBUYas of 2 days ago
  • Stock Information
  • Founded
  • INMB 2015
  • WNEB 1853
  • Country
  • INMB United States
  • WNEB United States
  • Employees
  • INMB N/A
  • WNEB N/A
  • Industry
  • INMB Biotechnology: Pharmaceutical Preparations
  • WNEB Savings Institutions
  • Sector
  • INMB Health Care
  • WNEB Finance
  • Exchange
  • INMB Nasdaq
  • WNEB Nasdaq
  • Market Cap
  • INMB 176.5M
  • WNEB N/A
  • IPO Year
  • INMB 2019
  • WNEB N/A
  • Fundamental
  • Price
  • INMB $7.52
  • WNEB $9.29
  • Analyst Decision
  • INMB Strong Buy
  • WNEB Buy
  • Analyst Count
  • INMB 3
  • WNEB 3
  • Target Price
  • INMB $24.33
  • WNEB $9.75
  • AVG Volume (30 Days)
  • INMB 256.0K
  • WNEB 64.2K
  • Earning Date
  • INMB 03-27-2025
  • WNEB 04-22-2025
  • Dividend Yield
  • INMB N/A
  • WNEB 3.01%
  • EPS Growth
  • INMB N/A
  • WNEB N/A
  • EPS
  • INMB N/A
  • WNEB 0.56
  • Revenue
  • INMB $14,000.00
  • WNEB $73,385,000.00
  • Revenue This Year
  • INMB N/A
  • WNEB N/A
  • Revenue Next Year
  • INMB N/A
  • WNEB $8.66
  • P/E Ratio
  • INMB N/A
  • WNEB $16.64
  • Revenue Growth
  • INMB N/A
  • WNEB N/A
  • 52 Week Low
  • INMB $4.32
  • WNEB $6.00
  • 52 Week High
  • INMB $12.72
  • WNEB $10.08
  • Technical
  • Relative Strength Index (RSI)
  • INMB 44.72
  • WNEB 51.13
  • Support Level
  • INMB $7.89
  • WNEB $9.00
  • Resistance Level
  • INMB $8.94
  • WNEB $9.58
  • Average True Range (ATR)
  • INMB 0.65
  • WNEB 0.18
  • MACD
  • INMB -0.06
  • WNEB 0.04
  • Stochastic Oscillator
  • INMB 25.65
  • WNEB 64.63

Stock Price Comparison Chart: INMB vs WNEB

INMB
WNEB
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober20250246810121416182022242628INMB VS WNEB

About INMB INmune Bio Inc. Common stock

INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use